Latest news


13/06/25 – New publication by PrIMAVeRa on systematic review of existing AMR transmission models




Interviews



Newsletters
From the partners

21/10/21 – How the EU Pharmaceutical Strategy could help prevent the next pandemic


14/04/21 – BioVersys receives €20 million in EU financing to support development of new antibiotics

30/03/21 – Astellas and TB Alliance Enter into a New Collaborative Research Agreement to Identify Lead Compounds for the Treatment of Tuberculosis

UNITE4TB Newsletter – June 2025
AMR Accelerator Newsletter – May 2025
ERA4TB Newsletter – May 2025
AMR Accelerator Newsletter – December 2024
UNITE4TB Newsletter – June 2024
AMR Accelerator Newsletter – June 2024